Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Atea Pharmaceuticals will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 12:20 p.m. EDT in New York. CEO and founder Jean-Pierre Sommadossi, together with other members of Atea management, will deliver the presentation, with a live webcast available and an archive posted on the company website for at least 90 days. Atea's Phase 3 program is evaluating a fixed-dose combination of bemnifosbuvir and ruzasvir for hepatitis C, while AT-587 is in Phase 1 development for hepatitis E.
Key figures
- Conference
- Morgan Stanley 24th Annual Global Healthcare Conference
- Presentation date
- September 15, 2026
- Presentation time
- 12:20 p.m. EDT
- Webcast archive days
- 90
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.